Posted On: 12/13/2012 9:51:54 AM
Post# of 23
Oncolytics Biotech Inc Announces Positive Top Line Reolysin Data For First Endpoint In Randomized Phase III Study In Head And Neck Cancers
http://www.reuters.com/finance/stocks/ONCY.O/...le/2659300
(0)
(0)Scroll down for more posts ▼
